FDA Considers Capping SPF Values At 50+ Despite Efficacy Data
This article was originally published in The Tan Sheet
Executive Summary
FDA might cap sun protection values at 50 or 50+ so as not to mislead consumers about the clinical benefit of sunscreens with higher SPF values, according to a proposed rule.
You may also be interested in...
CHPA: Sunscreen Efficacy Ceiling Is More Harmful Than SPF Claim Limit
FDA should not impose an efficacy ceiling on sunscreen formulations even if it caps sun protection factor label claims at 50 or 50+, industry stakeholders argue.
Sunscreen Firms Say SPF Cap Would Reduce User Protection
FDA’s proposal to cap SPF claims at 50 could undermine public health rather than enhance it, sunscreen marketers maintain.
FDA Strengthens Sunscreen Testing And Label Requirements
As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.